Skip to main content

Table 2 Growth outcomes and human milk fortification for all subjects and by human milk intake

From: Growth in VLBW infants fed predominantly fortified maternal and donor human milk diets: a retrospective cohort study

  

Group by proportion of enteral intake as human milk

 p value

 

All Subjects

<25%

25-50%

50-75%

>75%

All groups

>75% vs. <75%

Discharge weight, g, median (IQR)

2782 (2460, 3215)

3005 (2470, 3260)

2765 (2500, 3690)

2980 (2695, 3280)

2685 (2335, 3035)

0.008*

0.0006

Discharge weight z- score, median (IQR)

−0.94 (−1.43, -0.19)

−0.72 (−1.43, -0.19)

−0.69 (−1.36, -0.05)

−0.95 (−1.28, 0.12)

−1.07 (−1.52, -0.29)

0.36*

0.09

SGA at discharge n (%)

58 (34)

7 (41)

8 (27)

9 (25)

34 (39)

0.36*

0.18

Protein fortification, highest level

       

n (%)

       

2.0-2.3 g/dl

34 (20)

6 (35)

8 (27)

6 (17)

14 (16)

0.04

0.18

2.4-2.65 g/dl

84 (49)

6 (35)

14 (46)

16 (44)

48 (55)

  

2.5-2.7 g/dl

53 (31)

5 (29)

8 (27)

14 (39)

26 (30)

  

Change in weight z-score, birth to discharge, median (IQR)

−0.51‡ (−0.89, -0.03)

−0.1 (−0.61, 0.16)

−0.30 (−0.85, 0)

−0.32 (−0.73, 0.15)

−0.60 (−0.99, -0.15)

0.17*

0.03

  1. *ANOVA or Chi square across all groups.
  2. Chi square across all fortification levels and all human milk intake groups.
  3. ‡ p < 0.0001 – t-test of change in weight z score = 0, infants experienced significant negative change in weight z-score from birth to discharge.